Rapidly Growing Esophageal Carcinosarcoma Reduced by Neoadjuvant Radiotherapy Alone

Publisher： Karger

E-ISSN： 1662-0631|8|2|227-234

ISSN： 1662-0631

Source： Case Reports in Gastroenterology, Vol.8, Iss.2, 2014-06, pp. : 227-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Radiotherapy in the Multimodal Management of Esophageal Cancer

Digestive Diseases, Vol. 31, Iss. 1, 2013-06 ,pp. : 30-37

Karger

Access to resources Recommend Favorite

Comparison between margin-growing algorithms in radiotherapy software environments

By SMITH D W MORGAN A M POOLER A M THWAITES D I

British Journal of Radiology, Vol. 81, Iss. 965, 2008-05 ,pp. : 406-412

British Institute of Radiology

Access to resources Recommend Favorite

Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma

By Kosugi Shin-Ichi Kanda Tatsuo Nakagawa Satoru Ohashi Manabu Nishimaki Tadashi Hatakeyama Katsuyoshi

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 886-892

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery

By Motoori Masaaki

Esophagus, Vol. 8, Iss. 2, 2011-06 ,pp. : 81-87

Springer Publishing Company

Access to resources Recommend Favorite

Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma

By Sugawara Mitsuhiro

Esophagus, Vol. 10, Iss. 2, 2013-06 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite